In line with our findings of hyper-methylated DMRs in CXCL12, analysis of the TCGA dataset also revealed significant hyper-methylation of the CXCL12 promoter (p = 1.62425 × 10−12) in COAD tumors compared to controls. This evidence concerns the gene CXCL12 and colon adenocarcinoma.